Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 Business Wire - Tue Mar 24, 3:05PM CDT

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will...

MEDP : 460.30 (+2.02%)
ISRG
2 Healthcare Stocks with Exciting Potential and 1 We Avoid StockStory - Sun Mar 8, 11:43PM CDT

2 Healthcare Stocks with Exciting Potential and 1 We Avoid

MEDP : 460.30 (+2.02%)
ICUI : 125.38 (+0.96%)
ISRG : 452.77 (+0.03%)
CALM
3 Profitable Stocks for Long-Term Investors StockStory - Thu Mar 5, 10:33PM CST

3 Profitable Stocks for Long-Term Investors

CALM : 78.66 (+2.00%)
MEDP : 460.30 (+2.02%)
JBTM : 122.79 (-0.57%)
MEDP
Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group StockStory - Sun Mar 1, 9:34PM CST

Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group

MEDP : 460.30 (+2.02%)
MEDP
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know StockStory - Mon Feb 23, 11:00AM CST

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

MEDP : 460.30 (+2.02%)
TECH : 52.04 (+2.14%)
OSCR : 10.85 (-2.60%)
AZTA : 20.25 (+1.76%)
RVTY : 84.78 (+1.05%)
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates Newsfile - Sun Feb 22, 11:22PM CST

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP)...

MEDP : 460.30 (+2.02%)
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility PR Newswire - Wed Feb 18, 8:00AM CST

(NASDAQ: MEDP)

MEDP : 460.30 (+2.02%)
Lost Investment in Medpace Holdings, Inc. (MEDP)? Levi & Korsinsky Launches Securities Fraud Investigation Newsfile - Tue Feb 17, 3:38PM CST

New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP)...

MEDP : 460.30 (+2.02%)
MEDP
The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call StockStory - Sun Feb 15, 11:31PM CST

The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call

MEDP : 460.30 (+2.02%)
FIVE
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm StockStory - Wed Feb 11, 10:38PM CST

1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

MEDP : 460.30 (+2.02%)
FIVE : 219.82 (-0.86%)
ELAN : 23.44 (+1.34%)

Barchart Exclusives

Meta Platforms Just Made Entergy a Top Stock to Buy... and It Pays a 2.49% Dividend Barchart - Mon Mar 30, 6:30PM CDT
Meta’s decision to fully fund seven new natural gas plants, 240 miles of 500 kV transmission, batteries, and up to 2.5 GW of solar to power its giant Louisiana AI data center effectively gives Entergy a multi‑decade growth runway with limited bill pressure on other customers, which is a rare setup for a regulated utility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.